1. Home
  2. DRIO vs NSRX Comparison

DRIO vs NSRX Comparison

Compare DRIO & NSRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DarioHealth Corp.

DRIO

DarioHealth Corp.

HOLD

Current Price

$8.00

Market Cap

61.8M

Sector

Health Care

ML Signal

HOLD

NSRX

Nasus Pharma Ltd. Ordinary Shares

N/A

Current Price

$2.66

Market Cap

53.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DRIO
NSRX
Founded
2011
2019
Country
United States
Israel
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
61.8M
53.5M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
DRIO
NSRX
Price
$8.00
$2.66
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$60.00
$20.50
AVG Volume (30 Days)
7.8K
134.1K
Earning Date
03-19-2026
03-20-2026
Dividend Yield
N/A
N/A
EPS Growth
1559.02
N/A
EPS
10.12
N/A
Revenue
$7,394,000.00
N/A
Revenue This Year
$26.84
N/A
Revenue Next Year
$44.98
N/A
P/E Ratio
$0.81
N/A
Revenue Growth
43.02
N/A
52 Week Low
$0.38
$2.40
52 Week High
$17.74
$9.99

Technical Indicators

Market Signals
Indicator
DRIO
NSRX
Relative Strength Index (RSI) 31.48 27.45
Support Level $0.56 N/A
Resistance Level $12.36 $5.20
Average True Range (ATR) 0.68 0.42
MACD -0.14 -0.20
Stochastic Oscillator 8.39 8.93

Price Performance

Historical Comparison
DRIO
NSRX

About DRIO DarioHealth Corp.

DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.

About NSRX Nasus Pharma Ltd. Ordinary Shares

Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.

Share on Social Networks: